Blincyto 38,5mcg de polvo para concentrado y solucion para solucion para perfusion
Blincyto 38,5mcg de polvo para concentrado y solucion para solucion para perfusion
Commercialized
Register Number
1151047001
Prescription Type
Uso Hospitalario
Authorization Date
Dec 16, 2015
Dosage Form
POLVO PARA CONCENTRADO Y SOLUCIÓN PARA SOLUCIÓN PARA PERFUSION
Route: VÍA INTRAVENOSA
Product Details
Detailed information about this CIMA AEMPS approved pharmaceutical product.
Basic Information
Key regulatory and product classification details
Regulatory Details
Register Number1151047001
EMA Approved
Yes
Drug Classification
✗
Generic
No
✓
Orphan
Yes
✗
Biosimilar
No
✓
Commercialized
Yes
CIMA AEMPS Classification
INGREDIENTS (1)
BLINATUMOMABActive
Quantity: 38,5 µg
Name: BLINATUMOMAB
ATC CLASSIFICATION (3)
L01F
L01FX
L01FX07